LONDON, United Kingdom, October 21, 2026: Professional tennis players remaining in the International Tennis Integrity Agency’s Registered Testing Pool will have to provide a daily 60-minute window for anti-doping tests even while competing at tournaments from January 1, 2027, ending a longstanding exemption granted because of the sport’s unpredictable schedules. However, the ITIA is simultaneously reducing the size of that pool, with approximately 80% of its current members expected to move into an expanded testing group without the same daily time-slot requirement.
The restructuring, announced Wednesday as part of the transition to the revised World Anti-Doping Code, changes the administrative burden on different groups of professional players rather than simply placing every athlete under an identical new obligation. The ITIA says the overall number of players across its testing pools will remain broadly similar, while the frequency and volume of anti-doping testing are unlikely to change. The reform also introduces greater flexibility in cases involving proven contamination and certain recreational drug violations unrelated to sporting performance.
Tennis Anti-Doping Rules 2027: What Changes on January 1?
| Issue | Existing Arrangement | 2027 Change |
|---|---|---|
| Daily 60-minute testing window | Required for Registered Testing Pool players, with a specific tournament exemption in many circumstances | Required throughout the year, including during tournaments, for players remaining in the reduced Registered Testing Pool |
| Registered Testing Pool size | Broad group of designated players | Reduced, with approximately 80% of current members moving to an expanded pool |
| Expanded testing pool | Different monitoring arrangements already exist | Broader group without the Registered Testing Pool’s mandatory daily 60-minute window |
| Testing eligibility | Players can be selected for testing regardless of pool membership | Continues for players in and outside the pools |
| Testing frequency | Risk-based and intelligence-led | Overall volume is not expected to change materially |
| Contamination cases | Assessed under existing anti-doping rules | Additional protections and procedural flexibility in qualifying circumstances |
| Recreational drugs | Sanctions depend on the substance, circumstances and applicable rules | Greater flexibility, including rehabilitation-oriented approaches in certain cases |
| Player notifications | Individual pool assignments are administered by the ITIA | Players will be notified of their new assignments in November 2026 |
The distinction between the two principal testing groups is essential to understanding the announcement. It would be inaccurate to suggest that every professional tennis player must now reserve a daily hour for anti-doping authorities.
Why Tennis Previously Had an Exemption During Tournaments
Tennis presents particular logistical problems for whereabouts reporting.
A player can enter a tournament expecting to remain for a week, lose in the first round and leave the city almost immediately. Rain delays, late-night matches, injuries, withdrawals and changing practice arrangements further complicate an athlete’s daily schedule.
Under the existing Tennis Anti-Doping Programme, players in the Registered Testing Pool have generally been required to identify a daily 60-minute testing slot, but a specific exemption has applied to many competition dates when they were scheduled to participate in covered events.
That exemption does not mean players were previously immune from testing while competing. In-competition testing and other anti-doping obligations have continued to apply.
From January 2027, players retained in the Registered Testing Pool will lose this particular scheduling exemption and must maintain an accurate daily 60-minute window during tournament participation.
The ITIA explains the current framework through its official whereabouts guidance, including how location information supports unannounced sample collection.
Why the ITIA Is Moving Around 80% of Players Into Another Pool
The most important counterbalance to the tougher daily requirement is a substantial reduction in the number of players who must follow it.
According to the ITIA’s announcement, around four in five players currently in the Registered Testing Pool will be transferred to an expanded pool where the daily 60-minute window does not apply.
That makes the 2027 reform a redistribution of administrative obligations as well as a tightening of the rules for the smaller remaining group.
There is an important distinction between reducing the number of players who must file a specific daily window and reducing the number of players who can be tested.
Those are separate things.
The ITIA says it expects the number of players across the testing pools to remain broadly consistent and that testing frequency and volume are unlikely to change.
The practical result is that fewer athletes will face the highest level of whereabouts reporting, while the authority intends to preserve its capacity to select players for anti-doping tests.
The agency has not publicly disclosed which individual players will occupy each group in 2027. Those decisions will be communicated directly to the affected athletes in November.
How the 60-Minute Anti-Doping Window Actually Works
A 60-minute testing window is a designated period during which an athlete in the Registered Testing Pool must be available at the location specified in their whereabouts filing.
It is not a promise that a doping-control officer will appear every day, nor does it restrict testing to that particular hour.
Anti-doping officers can select players for testing at other times as permitted by the applicable rules. The daily window provides one reliable opportunity for an unannounced visit.
Players generally manage their whereabouts information through ADAMS, the World Anti-Doping Agency’s athlete administration and management platform.
The practical challenge during tournaments is that an athlete may not know exactly when a match will begin or finish, how long recovery will take or whether travel plans will change.
For players remaining in the smaller pool, maintaining accurate information will therefore require consistent coordination with their support teams.
A Practical Example of the New Tournament Obligation
Consider a player who identifies a daily testing window at their accommodation but subsequently receives a revised match schedule that makes the selected location unavailable.
Under the new requirements, a player in the Registered Testing Pool must manage their whereabouts information so that the reported slot remains accurate.
Whether a particular incident becomes a missed test or filing failure depends on the detailed rules, notice requirements and investigation of the circumstances. An unexpected scheduling change does not automatically establish an anti-doping violation.
This hypothetical example illustrates the administrative challenge rather than reporting any actual player’s conduct.
Registered Testing Pool vs. Expanded Testing Pool: Who Faces What?
| Requirement | Reduced Registered Testing Pool | Expanded Testing Pool |
|---|---|---|
| Daily 60-minute window during tournaments | Yes | No |
| Ability to be selected for testing | Yes | Yes |
| Obligation to provide a sample when properly requested | Yes | Yes |
| Whereabouts reporting arrangements | Detailed requirements apply | Different, less intensive requirements may apply |
| Individual 2027 assignment | To be communicated by ITIA | To be communicated by ITIA |
| Exemption from anti-doping rules | No | No |
The second column should not be read as a guarantee that players in the expanded pool have no reporting responsibilities at all. Their specific obligations depend on the applicable pool rules and the information supplied by the ITIA.
Nor is the smaller Registered Testing Pool necessarily limited to a fixed ranking threshold throughout the season. The ITIA operates a risk-based system and can adjust testing arrangements.
What Happens if a Tennis Player Misses an Anti-Doping Test?
Anti-doping rules distinguish several forms of noncompliance, and that distinction matters when discussing potential punishment.
A missed test under the whereabouts system is not automatically the same as a refusal to submit to sample collection.
A whereabouts failure can involve a missed test during the designated window or a filing failure, such as not maintaining the required information under applicable rules.
Under the 2026 Tennis Anti-Doping Programme, any combination of three qualifying missed tests or filing failures within a 12-month period can constitute an anti-doping rule violation for a player in the Registered Testing Pool.
Individual incidents require assessment under the applicable procedures. A reported failure is not equivalent to a positive drug test, and a single missed-test allegation does not automatically establish a suspension.
Refusing or failing without compelling justification to provide a sample after an authorized request is a separate, potentially much more serious violation. The ITIA has warned that refusal can carry a suspension of up to four years, depending on the circumstances and applicable rules.
These provisions are part of the wider Tennis Anti-Doping Programme, which also governs prohibited substances, testing, results management and disciplinary procedures.
Why the 2027 Changes Also Matter for Contamination Cases
The revised framework does more than alter the reporting of player locations.
According to the ITIA, it will provide additional protection for athletes who can establish that an adverse test result resulted from contamination, including exposure associated with medication, food, drink, the environment or another person.
This is an important procedural development because the presence of a prohibited substance does not, by itself, establish the precise circumstances in which it entered an athlete’s system.
However, contamination protections are not automatic exemptions. Athletes still need to satisfy the relevant evidentiary requirements, and each case must be evaluated under the rules that apply to it.
Why Jannik Sinner’s Earlier Case Is Relevant
The distinction between detecting a prohibited substance and determining an athlete’s responsibility became particularly prominent during Jannik Sinner’s anti-doping case.
Sinner tested positive for clostebol in samples collected in 2024. The case involved an explanation of contamination linked to treatment by a member of his support team, an initial ITIA decision and subsequent proceedings involving the World Anti-Doping Agency.
The Sports Encounter revisited that history in its account of Sinner’s Wimbledon 2026 title campaign, placing the earlier proceedings in the context of his subsequent career.
The ITIA’s 2025 annual review also identified the case as part of the wider discussion about how the anti-doping system evaluates fault, intent and scientific complexity.
It would nevertheless be incorrect to assume the revised 2027 provisions would necessarily have produced a different outcome in Sinner’s case. Rules must be assessed in their correct legal and factual context, and earlier decisions cannot simply be rewritten using later standards.
Recreational Drug Cases May Receive More Flexible Treatment
The 2027 changes are also intended to allow greater flexibility in certain cases involving recreational drugs unrelated to sporting performance.
That could include rehabilitation-oriented responses when the applicable conditions are satisfied.
The central distinction is between deliberate attempts to enhance sporting performance and other prohibited-substance cases that may involve very different circumstances.
This does not mean recreational substances are being removed from the anti-doping framework or that players can assume such cases will carry no sanction.
Eligibility for any reduced or alternative consequence will depend on the revised rules and the facts established during results management.
What the Rule Change Means for Players Traveling Across the Tennis Calendar
The modern professional tennis schedule regularly requires international travel across continents, changes in accommodation and rapid transitions between tournaments.
That makes accurate whereabouts reporting more demanding than simply submitting a permanent home address.
A player might finish a tournament earlier than expected, move to another city for treatment or preparation, or change plans because of illness or injury.
In its coverage of Iga Świątek’s withdrawal from Ningbo, The Sports Encounter examined how an injury-related decision can abruptly change a player’s competitive calendar.
That example is relevant to the logistical nature of tennis, not an allegation that Świątek has violated any anti-doping requirement.
Similarly, Sinner’s decision to end his 2026 season because of a knee injury illustrates how an athlete’s planned schedule can change substantially during the year.
For players remaining in the Registered Testing Pool, the new requirement means those adjustments must be considered alongside their daily testing-slot obligations.
The exact administrative burden will vary according to the athlete’s pool membership, travel pattern and support arrangements.
Retirement and Returning to Competition Create Different Anti-Doping Questions
The testing-pool system also interacts with professional retirement and possible returns to competition.
Players who officially retire are subject to rules governing withdrawal from the active testing system, and a return to professional tennis may require advance compliance with reinstatement procedures.
The Sports Encounter recently covered Gaël Monfils’ registered retirement in October 2026, noting the separate sporting implications of his departure from professional tennis.
His retirement is not an anti-doping violation. The relevance here is that retirement status and testing-pool status are governed by formal procedures rather than simply whether a player is appearing in tournaments.
Those procedures matter whenever a previously retired player considers returning to competition.
Will the New Rules Increase the Number of Drug Tests?
Not necessarily.
The ITIA has said that testing frequency and overall volume are unlikely to change significantly as a result of the restructuring.
That means the headline figure of a daily testing window should not be mistaken for an announcement of thousands of additional tests.
The practical change concerns the availability and reporting obligations of a smaller designated pool, rather than an announced expansion in laboratory testing capacity.
The ITIA’s underlying testing approach remains risk-based and intelligence-led, with sample collection possible at tournaments, training facilities, accommodation and other locations.
For context, the agency’s existing elite-player coverage involving Sinner’s extraordinary 2024-2026 consistency shows the intensity of the modern international schedule. That sporting workload is relevant to understanding travel and reporting demands, although it is not evidence of any player’s individual testing arrangements.
Why Stronger Testing Rules Must Also Protect Player Rights
An effective anti-doping program requires access to athletes without advance notice. That protects the credibility of testing by reducing opportunities to avoid detection.
But whereabouts systems also collect sensitive information about an athlete’s daily movements and schedule.
The existing ITIA framework states that whereabouts data must remain confidential, be used for legitimate anti-doping purposes and be handled under applicable information-protection requirements.
Stronger access requirements therefore increase the importance of clear procedures, proportionate obligations and reliable data handling.
The broader principle is relevant to governance across international sport. In The Sports Encounter’s analysis of doping-related sporting sanctions and individual accountability, we examined why decisions affecting athletes require evidence and proportionate procedures.
The 2027 tennis reforms offer another test of that principle: maintaining rigorous oversight while distinguishing between intentional cheating, administrative noncompliance and proven accidental exposure.
What Happens Between Now and January 2027?
The next important step will come in November 2026, when the ITIA informs players of their assignments to the revised testing pools.
| Period | Expected Development | What It Will Clarify |
|---|---|---|
| October 21, 2026 | ITIA announces the 2027 changes | New tournament whereabouts rule and pool restructuring |
| November 2026 | Individual pool notifications | Which reporting system each affected player must follow |
| Before January 2027 | Player guidance and preparation | Administrative processes and compliance requirements |
| January 1, 2027 | Revised anti-doping framework takes effect | New requirements begin applying |
Public disclosure of individual 2027 classifications is not expected. Therefore, media reports should not assume that a named player belongs to the reduced Registered Testing Pool unless that information is officially established.
The next important evidence will be the ITIA’s finalized player guidance, the specific revised regulations and the administration of the system after implementation.
Frequently Asked Questions About Tennis Anti-Doping Rules in 2027
When Do the New Tennis Anti-Doping Rules Begin?
The revised requirements are scheduled to take effect on January 1, 2027.
Will Every Tennis Player Need a Daily 60-Minute Testing Window?
No. The obligation will apply to players remaining in the reduced Registered Testing Pool. Around 80% of current pool members are expected to move to an expanded group without that particular requirement.
What Is a Registered Testing Pool?
It is a designated group of athletes subject to detailed whereabouts requirements that support unannounced anti-doping testing.
Why Is Tennis Losing Its Tournament Exemption?
The revised World Anti-Doping Code requires consistent daily testing-slot obligations for athletes remaining in the Registered Testing Pool, ending the special accommodation previously granted to tennis during many tournament periods.
Can Players Outside the Registered Testing Pool Still Be Tested?
Yes. Pool membership does not determine whether a player can be selected for an anti-doping test.
Does Missing One Testing Window Automatically Mean a Ban?
No. Whether an incident constitutes a whereabouts failure depends on the applicable rules and circumstances. A single alleged missed test does not automatically establish an anti-doping rule violation.
What Happens if a Player Refuses an Anti-Doping Test?
Refusing or failing to provide a sample without compelling justification can constitute a separate anti-doping rule violation and may result in a lengthy suspension, potentially up to four years.
Will the New Rules Increase Anti-Doping Testing Volume?
The ITIA has said that overall testing frequency and volume are unlikely to change significantly as a result of the restructuring.
Will Players Receive Their New Testing-Pool Assignments?
Yes. The ITIA expects to notify affected players during November 2026, although individual assignments will not be made public.
The Sports Encounter’s Analysis: A Tougher Rule for Fewer Players
The apparent contradiction in the 2027 announcement is also the key to understanding it.
Tennis is removing an exemption that previously made tournament weeks easier for players in the Registered Testing Pool. At the same time, it is moving most current members out of that pool and into a less demanding reporting structure.
For the smaller group that remains, compliance becomes more demanding during competition. For those transferred to the expanded pool, the daily reporting requirement becomes less intensive.
The overall testing program is expected to continue operating at roughly its existing scale.
That creates two separate questions for evaluating the reform. First, whether the reduced Registered Testing Pool allows the ITIA to maintain effective access to the athletes presenting the greatest testing priorities. Second, whether the reporting system can be administered fairly when competition schedules, injuries and travel plans change unexpectedly.
The additional flexibility concerning contamination and certain recreational-drug cases is equally significant. A credible anti-doping system must be capable of identifying deliberate wrongdoing while also distinguishing it from other circumstances established through reliable evidence.
The immediate test will come in November, when players learn which pool they have entered. The larger test begins in January, when the revised requirements become operational across the international tennis calendar.
Editorial methodology: This report draws on the ITIA’s October 21, 2026 announcement as reported by Reuters, together with the agency’s published whereabouts guidance and Tennis Anti-Doping Programme. Existing 2026 provisions are distinguished from the announced 2027 changes. Examples concerning travel and player schedules are explanatory and do not imply misconduct by named athletes.